Based on the CTT Pharmaceutical Holdings Inc stock forecast from 0 analysts, the average analyst target price for CTT Pharmaceutical Holdings Inc is not available over the next 12 months. CTT Pharmaceutical Holdings Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CTT Pharmaceutical Holdings Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, CTT Pharmaceutical Holdings Inc’s stock price was USD 0.07. CTT Pharmaceutical Holdings Inc’s stock price has changed by -4.35% over the past week, +10.00% over the past month and +39,302.99% over the last year.
No recent analyst target price found for CTT Pharmaceutical Holdings Inc
No recent average analyst rating found for CTT Pharmaceutical Holdings Inc
Company Overview CTT Pharmaceutical Holdings Inc
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada. Read Less
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infu...Read More
Frequently Asked Questions About CTT Pharmaceutical Holdings Inc (CTTH) Stock
Stock Target Advisor's fundamental analysis for CTT Pharmaceutical Holdings Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on CTTH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CTTH's stock to indicate what its average analyst target is.
CTTH stock's Price/Earning ratio is 3.50.
Our analysis grades CTTH stock's Price / Earning ratio at C-. This means that CTTH stock's Price/Earning ratio is above 29% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this CTTH may be undervalued for its sector.
The last closing price of CTTH's stock was USD 0.07.
The most recent market capitalization for CTTH is USD 3.54M.
Unfortunately we do not have enough analyst data on CTTH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CTT Pharmaceutical Holdings Inc's stock.
As per our most recent records CTT Pharmaceutical Holdings Inc has 0 Employees.
CTT Pharmaceutical Holdings Inc's registered address is 429 Kent Street unit 112, Ottawa, ON, Canada, K2P 2B4.
You can get more information about it from CTT Pharmaceutical Holdings Inc's website at https://www.cttpharmaceuticals.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About CTT Pharmaceutical Holdings Inc (CTTH) Stock
Stock Target Advisor's fundamental analysis for CTT Pharmaceutical Holdings Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on CTTH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CTTH's stock to indicate what its average analyst target is.
CTTH stock's Price/Earning ratio is 3.50.
Our analysis grades CTTH stock's Price / Earning ratio at C-. This means that CTTH stock's Price/Earning ratio is above 29% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange.
Based on this CTTH may be undervalued for its sector.
The last closing price of CTTH's stock was USD 0.07.
The most recent market capitalization for CTTH is USD 3.54M.
Unfortunately we do not have enough analyst data on CTTH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CTT Pharmaceutical Holdings Inc's stock.
As per our most recent records CTT Pharmaceutical Holdings Inc has 0 Employees.
CTT Pharmaceutical Holdings Inc's registered address is 429 Kent Street unit 112, Ottawa, ON, Canada, K2P 2B4.
You can get more information about it from CTT Pharmaceutical Holdings Inc's website at https://www.cttpharmaceuticals.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CTTH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
